dalteparin has been researched along with Abnormalities, Congenital in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Multivariate logistic regression models were used to examine associations between first- and third-trimester exposure to enoxaparin, major malformations, and other adverse birth outcomes, adjusted for confounders." | 1.46 | The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort Study. ( Daniel, S; Fishman, B; Gorodischer, R; Koren, G; Levy, A; Matok, I; Shlomo, M; Wiznitzer, A, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shlomo, M | 1 |
| Gorodischer, R | 1 |
| Daniel, S | 1 |
| Wiznitzer, A | 1 |
| Matok, I | 1 |
| Fishman, B | 1 |
| Koren, G | 1 |
| Levy, A | 1 |
| Santos, M | 1 |
| Cruz, S | 1 |
| Casimiro, C | 1 |
| Biscoito, M | 1 |
| Costa, M | 1 |
| Winger, EE | 1 |
| Reed, JL | 1 |
| Ashoush, S | 1 |
| El-Toukhy, T | 1 |
| Ahuja, S | 1 |
| Taranissi, M | 1 |
3 other studies available for dalteparin and Abnormalities, Congenital
| Article | Year |
|---|---|
The Fetal Safety of Enoxaparin Use During Pregnancy: A Population-Based Retrospective Cohort Study.
Topics: Anticoagulants; Apgar Score; Cohort Studies; Congenital Abnormalities; Enoxaparin; Female; Fetal Dev | 2017 |
[Vertebral artery dissection associated with MURCS syndrome].
Topics: 46, XX Disorders of Sex Development; Anticoagulants; Brain Ischemia; Congenital Abnormalities; Diplo | 2017 |
Birth defect rates in women using Adalimumab (Humira(®) ) to treat immunologic-based infertility in IVF patients.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Congenital Abnormali | 2011 |